Certified by Founder Lodge
Vida Ventures, LLC
United States - Boston, Massachusetts INVESTOR
1 Disclosed Funding Rounds $60,000,000
9 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakt
| Company | Date | Round | Raised |
|---|---|---|---|
 Volastra Therapeutics | March, 08 ,2023 | Series A | $60,000,000 |
 Quanta Therapeutics | May, 23 ,2023 | Series D | $50,000,000 |
 Kyverna Therapeutics | August, 03 ,2023 | Series B | $60,000,000 |
 ReCode Therapeutics | September, 20 ,2023 | Series B | $50,000,000 |
 Avalyn Pharma Inc. | September, 28 ,2023 | Series C | $175,000,000 |
 Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
 Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
 Scorpion Therapeutics | July, 17 ,2024 | Series C | $150,000,000 |
 Candid Therapeutics | September, 10 ,2024 | Unknown | $370,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
experial | $2,198,930 | (Apr 3, 2025)
Further AI | $5,000,000 | (Apr 3, 2025)
